Filing Details
- Accession Number:
- 0000899243-21-042938
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-03 21:18:09
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-11-03 21:18:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1241357 | I Jean Liu | 21823 30Th Drive Se Bothell WA 98021 | Gc/Evp, Leg Afairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-01 | 34,876 | $35.95 | 103,967 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-01 | 2,080 | $173.00 | 101,887 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-01 | 2,588 | $174.20 | 99,299 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-01 | 753 | $175.08 | 98,546 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-01 | 8,776 | $177.29 | 89,770 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-01 | 14,457 | $178.07 | 75,313 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-01 | 6,222 | $179.14 | 69,091 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-11-01 | 34,876 | $0.00 | 34,876 | $35.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-10-01 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on November 13, 2020.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $172.50 to $173.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $173.59 to $174.44. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $174.71 to $175.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $176.72 to $177.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $177.72 to $178.64. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $178.80 to $179.34. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 11/17/15 and monthly thereafter until all options were fully vested on 11/17/18.
Billionaire Hedge Funds
